Literature DB >> 25492913

The Epidemiology of Chlamydia trachomatis Organism Load During Genital Infection: A Systematic Review.

Lenka A Vodstrcil1, Ruthy McIver2, Wilhelmina M Huston3, Sepehr N Tabrizi4, Peter Timms5, Jane S Hocking6.   

Abstract

BACKGROUND: The role of organism load in Chlamydia trachomatis infection is not well understood. We conducted a systematic review to investigate the epidemiology of C. trachomatis organism load in human genital chlamydia infection.
METHODS: Embase, PubMed, and Medline databases were searched for literature published through August 2014. English-language publications that quantified load in humans were eligible. Participant characteristics and laboratory data were extracted.
RESULTS: A total of 737 records were identified, and 29 publications involving 40 883 participants were included. In women, load was highest for cervical swabs and lowest for urine specimens. In men, load was highest for rectal swabs and similar for urethral swabs and urine specimens. Evidence of any association between load and age, serovar, risk of transmission, hormone levels, and concurrent sexually transmitted infections was inconsistent. Eight of 9 culture-based studies found an association between load and signs and symptoms, in contrast with only 3 of 8 nucleic acid amplification test (NAAT)-based studies (P = .03).
CONCLUSION: Chlamydia organism load varies by specimen type and site of sampling, and viable chlamydia organism load may be a more important indicator of severity of infection than total load measured by NAAT.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Chlamydia trachomatis; culture; nucleic acid amplification; organism load; systematic review

Mesh:

Year:  2014        PMID: 25492913     DOI: 10.1093/infdis/jiu670

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  27 in total

1.  Phosphate substitution in an AlOOH - TLR4 adjuvant system (SPA08) modulates the immunogenicity of Serovar E MOMP from Chlamydia trachomatis.

Authors:  Lucian Visan; Violette Sanchez; Margaux Kania; Aymeric de Montfort; Luis M de la Maza; Salvador Fernando Ausar
Journal:  Hum Vaccin Immunother       Date:  2016-04-22       Impact factor: 3.452

2.  Microbiological Characteristics of Chlamydia trachomatis and Neisseria gonorrhoeae Infections in South African Women.

Authors:  Jan Henk Dubbink; Dewi J de Waaij; Myrte Bos; Lisette van der Eem; Cécile Bébéar; Nontembeko Mbambazela; Sander Ouburg; Remco P H Peters; Servaas A Morré
Journal:  J Clin Microbiol       Date:  2015-10-28       Impact factor: 5.948

3.  Bacterial Load of Chlamydia trachomatis in the Posterior Oropharynx, Tonsillar Fossae, and Saliva among Men Who Have Sex with Men with Untreated Oropharyngeal Chlamydia.

Authors:  Tiffany R Phillips; Christopher K Fairley; Kate Maddaford; Jennifer Danielewski; Jane S Hocking; David Lee; Deborah A Williamson; Gerald Murray; Fabian Kong; Vesna De Petra; Catriona S Bradshaw; Marcus Y Chen; Rebecca Wigan; Anthony Snow; Benjamin P Howden; Suzanne M Garland; Eric P F Chow
Journal:  J Clin Microbiol       Date:  2019-12-23       Impact factor: 5.948

4.  Repeated Chlamydia trachomatis infections are associated with lower bacterial loads.

Authors:  K Gupta; R K Bakshi; B Van Der Pol; G Daniel; L Brown; C G Press; R Gorwitz; J Papp; J Y Lee; W M Geisler
Journal:  Epidemiol Infect       Date:  2018-10-04       Impact factor: 2.451

5.  Performance of self-collected penile-meatal swabs compared to clinician-collected urethral swabs for the detection of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium by nucleic acid amplification assays.

Authors:  Laura Dize; Perry Barnes; Mathilda Barnes; Yu-Hsiang Hsieh; Vincent Marsiglia; Della Duncan; Justin Hardick; Charlotte A Gaydos
Journal:  Diagn Microbiol Infect Dis       Date:  2016-07-25       Impact factor: 2.803

6.  A Recombinant Chlamydia trachomatis MOMP Vaccine Elicits Cross-serogroup Protection in Mice Against Vaginal Shedding and Infertility.

Authors:  Delia F Tifrea; Sukumar Pal; Luis M de la Maza
Journal:  J Infect Dis       Date:  2020-01-02       Impact factor: 5.226

7.  Performance of Chlamydia trachomatis OmcB Enzyme-Linked Immunosorbent Assay in Serodiagnosis of Chlamydia trachomatis Infection in Women.

Authors:  Kanupriya Gupta; LaDraka' Brown; Rakesh K Bakshi; Christen G Press; Xiaofei Chi; Rachel J Gorwitz; John R Papp; William M Geisler
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

8.  T cell phenotypes in women with Chlamydia trachomatis infection and influence of treatment on phenotype distributions.

Authors:  Brian M O Ogendi; Rakesh K Bakshi; Kanupriya Gupta; Richa Kapil; LaDraka T Brown; Stephen J Jordan; Steffanie Sabbaj; Christen G Press; Jeannette Y Lee; William M Geisler
Journal:  Microbes Infect       Date:  2017-12-26       Impact factor: 2.700

9.  Higher organism load associated with failure of azithromycin to treat rectal chlamydia.

Authors:  F Y S Kong; S N Tabrizi; C K Fairley; S Phillips; G Fehler; M Law; L A Vodstrcil; M Chen; C S Bradshaw; J S Hocking
Journal:  Epidemiol Infect       Date:  2016-05-16       Impact factor: 4.434

Review 10.  Diagnosis of Chlamydia trachomatis genital infections in the era of genomic medicine.

Authors:  Seema Shetty; Christina Kouskouti; Uwe Schoen; Nikolaos Evangelatos; Shashidhar Vishwanath; Kapaettu Satyamoorthy; Franz Kainer; Angela Brand
Journal:  Braz J Microbiol       Date:  2021-06-23       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.